vs
Side-by-side financial comparison of INNEOVA Holdings Ltd (INEO) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $30.8M, roughly 1.4× INNEOVA Holdings Ltd). INNEOVA Holdings Ltd runs the higher net margin — 0.8% vs -17.2%, a 18.0% gap on every dollar of revenue. Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-1.5M).
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
INEO vs STIM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.8M | $41.8M |
| Net Profit | $243.0K | $-7.2M |
| Gross Margin | 19.3% | 52.0% |
| Operating Margin | 3.6% | -12.1% |
| Net Margin | 0.8% | -17.2% |
| Revenue YoY | — | 85.7% |
| Net Profit YoY | — | 43.2% |
| EPS (diluted) | $0.02 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $41.8M | ||
| Q3 25 | — | $37.3M | ||
| Q2 25 | $30.8M | $38.1M | ||
| Q1 25 | — | $32.0M | ||
| Q4 24 | — | $22.5M | ||
| Q3 24 | — | $18.5M | ||
| Q2 24 | — | $16.4M | ||
| Q1 24 | — | $17.4M |
| Q4 25 | — | $-7.2M | ||
| Q3 25 | — | $-9.0M | ||
| Q2 25 | $243.0K | $-10.1M | ||
| Q1 25 | — | $-12.7M | ||
| Q4 24 | — | $-12.7M | ||
| Q3 24 | — | $-13.3M | ||
| Q2 24 | — | $-9.8M | ||
| Q1 24 | — | $-7.9M |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 45.9% | ||
| Q2 25 | 19.3% | 46.6% | ||
| Q1 25 | — | 49.2% | ||
| Q4 24 | — | 66.2% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.0% | ||
| Q1 24 | — | 75.1% |
| Q4 25 | — | -12.1% | ||
| Q3 25 | — | -19.6% | ||
| Q2 25 | 3.6% | -21.1% | ||
| Q1 25 | — | -34.4% | ||
| Q4 24 | — | -51.0% | ||
| Q3 24 | — | -41.7% | ||
| Q2 24 | — | -51.7% | ||
| Q1 24 | — | -39.4% |
| Q4 25 | — | -17.2% | ||
| Q3 25 | — | -24.3% | ||
| Q2 25 | 0.8% | -26.6% | ||
| Q1 25 | — | -39.6% | ||
| Q4 24 | — | -56.4% | ||
| Q3 24 | — | -72.0% | ||
| Q2 24 | — | -59.8% | ||
| Q1 24 | — | -45.2% |
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | $0.02 | $-0.15 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.34 | ||
| Q3 24 | — | $-0.44 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $28.1M |
| Total DebtLower is stronger | $2.9M | $65.8M |
| Stockholders' EquityBook value | $11.2M | $22.4M |
| Total Assets | $52.6M | $141.6M |
| Debt / EquityLower = less leverage | 0.26× | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.1M | ||
| Q3 25 | — | $28.0M | ||
| Q2 25 | $2.1M | $11.0M | ||
| Q1 25 | — | $20.2M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | — | $42.6M | ||
| Q1 24 | — | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | $2.9M | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | — | $22.4M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | $11.2M | $27.1M | ||
| Q1 25 | — | $35.5M | ||
| Q4 24 | — | $27.7M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $27.7M |
| Q4 25 | — | $141.6M | ||
| Q3 25 | — | $145.5M | ||
| Q2 25 | $52.6M | $134.7M | ||
| Q1 25 | — | $142.0M | ||
| Q4 24 | — | $140.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | 0.26× | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-301.0K | $908.0K |
| Free Cash FlowOCF − Capex | $-1.5M | $692.0K |
| FCF MarginFCF / Revenue | -4.8% | 1.7% |
| Capex IntensityCapex / Revenue | 3.8% | 0.5% |
| Cash ConversionOCF / Net Profit | -1.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $908.0K | ||
| Q3 25 | — | $-785.0K | ||
| Q2 25 | $-301.0K | $-3.5M | ||
| Q1 25 | — | $-17.0M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-5.4M | ||
| Q2 24 | — | $-5.0M | ||
| Q1 24 | — | $-12.0M |
| Q4 25 | — | $692.0K | ||
| Q3 25 | — | $-899.0K | ||
| Q2 25 | $-1.5M | $-3.8M | ||
| Q1 25 | — | $-17.2M | ||
| Q4 24 | — | $-8.7M | ||
| Q3 24 | — | $-5.8M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-12.4M |
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | -4.8% | -9.9% | ||
| Q1 25 | — | -53.8% | ||
| Q4 24 | — | -38.6% | ||
| Q3 24 | — | -31.3% | ||
| Q2 24 | — | -34.0% | ||
| Q1 24 | — | -71.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | 3.8% | 0.7% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
